Navigation Links
Dr. Joel Posener Joins PharmaNet as Executive Medical Director, Neuroscience
Date:6/29/2011

PRINCETON, N.J., June 29, 2011 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that Joel Posener, MD, has joined the Company as Executive Medical Director, Neuroscience. Dr. Posener will support PharmaNet project teams conducting clinical trials in psychiatry and neurology, and will provide drug development advice to clients in the area of neuroscience.

"We are thrilled Joel has joined PharmaNet," said Steven Leventer, PhD, Vice President and General Manager, Neuroscience. "His distinguished medical and clinical credentials will be a valuable addition to PharmaNet's experienced neuroscience team. Joel's appointment further demonstrates our commitment to help our clients develop innovative neuroscience therapeutics."

Dr. Posener obtained his medical degree from McGill University, completed a residency in psychiatry and fellowship in psychiatric research at Harvard Medical School and Massachusetts Mental Health Center, and is board certified in Psychiatry. Prior to joining PharmaNet, Dr. Posener held roles at Wyeth as Senior Director, Neuroscience Medical Research and Senior Director, Early Development and Clinical Pharmacology. He directed Phase II projects in a variety of psychiatric indications including cognitive impairment in schizophrenia, bipolar disorder and depression. Dr. Posener has also managed early clinical development programs in schizophrenia, depression and Alzheimer's disease.

Before joining the pharmaceutical industry, Dr. Posener served on the faculty of Harvard Medical School and Washington University School of Medicine in St. Louis, where he was also Medical Director of Metropolitan St. Louis Psychiatric Center, an academically affiliated public psychiatric hospital. He has published
'/>"/>

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Eduard Alberts, Ph.D. Joins Sanford Rose Associates - San Francisco
2. Amicus Therapeutics Joins Russell 3000® Index
3. Dr. H. Daniel Perez Joins Celtaxsys Board of Directors
4. Governor Gray Davis Joins Genesis Biopharma as Chairman of Corporate Advisory Board
5. Matthias Spaenle, MD, Joins Oppenheimers Investment Banking Group as Managing Director - Healthcare
6. William T. Boehm Joins Neogens Board of Directors
7. Scott Garrett Joins Water Street Healthcare Partners
8. Sigma® Life Science Joins AMDeCs Vendor Partnership Program, Further Enhancing Value to Academic Medical Research Centers
9. Ed Weimer Joins Delta Point, Inc. as Executive Account Director
10. Former Capital One Director and Business Leader Stanley I. Westreich Joins Neuralstems Board
11. Former Cerner Chief Operating Officer Joins Netsmart Technologies Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)...  Biotest Pharmaceuticals Corporation (BPC), a leading developer of ... of its newest plasma collection center located at 2235 ... . The over 16,000 square foot state-of-the-art facility ... th 2015 and brings the total number of ... "This facility represents another milestone in our continued efforts ...
(Date:3/31/2015)... -- Materials in Society Lecture Series at ... 2015   Elsevier , a world-leading provider ... publishing home of Materials Today , announced that its ... Materials in Society  Lecture Series . The inaugural ... International Conference on Materials for Advanced Technologies (ICMAT) to ...
(Date:3/31/2015)... N.J. , March 31, 2015  Bayer ... Broad Institute of Massachusetts Institute of Technology (MIT) ... drug discovery. The goal of this new part ... human genetics to help create new cardiovascular therapies. ... collaboration with the Broad Institute to the area ...
(Date:3/31/2015)... NEW YORK , March 31, 2015 /PRNewswire/ ... biopharmaceutical company advancing protein biologic therapies and oncology ... marketing partner, Hanmi Pharmaceutical Co., Ltd ("Hanmi") (KSE: ... the country,s Ministry of Food and Drug Safety ... (KTR) for MuGard, its oncology supportive-care treatment for ...
Breaking Biology Technology:Biotest Pharmaceuticals Corporation Announces the Opening of its Newest Plasma Collection Facility in Conway, Arkansas 2Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 2Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 3Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 2Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 3PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3
... Some of the first data from a new orbiting infrared ... analogy galaxies in general - is making new stars at ... findings from NASA's Spitzer Space Telescope were announced today (May ... a University of Wisconsin-Madison astronomer and the leader of a ...
... for 10 years in tax credits , ,MADISON ... Wisconsin was discussed at an economic development breakfast panel ... Business Development Center at the MG&E Innovation Center. A ... and private sector, discussed the implications of new tax-credit ...
... Formulatrix Inc. and Bruker AXS have ... incubation and imaging products. , ,Crystal Farm, developed by ... International , is an integrated product for incubation and ... design drugs. The system will now work with Formulatrixs ...
Cached Biology Technology:Milky Way churning out new stars at a furious pace 2Milky Way churning out new stars at a furious pace 3The impact of ACT 255 on the future of high-tech investment in Wisconsin 2Protein-crystal companies join forces for better imaging process 2
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4stcg3/india_sensors ) ... Sensors Market Forecast and Opportunities 2020" report ... is projected to grow at a CAGR over ... industrial and healthcare sectors are the key application ... adoption of MEMS technology in sensors is growing ...
(Date:3/20/2015)... 19, 2015 Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ... - Global Strategic Business Report" report to their offering. ... Biometrics in US$ Thousands. The report provides separate comprehensive analytics ... Japan , Europe , ... Latin America . Annual estimates ...
(Date:3/17/2015)... MINNETONKA, Minn. , March 17, 2015 /PRNewswire/ ... sciences technology company specializing in clinical study management ... will be in attendance at ARENA,s Outsourcing in ... Cary, NC.  This event provides an excellent forum ... company,s easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... reliable indicators to predict that a person will develop type ... produced in the pancreas and is the hormone responsible for ... body, such as muscles. Insulin resistance is characterized by the ... a greater production of insulin by the pancreas. When the ...
... Cellmark Inc.,(Nasdaq: ORCH ), a leading worldwide provider of ... quarter of 2008. , Total ... $15.6 million for the third quarter of 2007. The decrease ... year ago was largely due,to lower revenues in the U.K. , ...
... ARLINGTON, Va., Nov. 18 Stanley, Inc.,(NYSE: ... professional,services to the U.S. federal government, today announced that ... International Corporation (NYSE: SAI ) awarded,a four-year, ... if,all three option years are exercised. With this award, ...
Cached Biology News:Researchers at IRB Barcelona produce more data on key genes in diabetes 2Researchers at IRB Barcelona produce more data on key genes in diabetes 3Orchid Cellmark Reports Third Quarter 2008 Financial Results 2Orchid Cellmark Reports Third Quarter 2008 Financial Results 3Orchid Cellmark Reports Third Quarter 2008 Financial Results 4Orchid Cellmark Reports Third Quarter 2008 Financial Results 5Orchid Cellmark Reports Third Quarter 2008 Financial Results 6Orchid Cellmark Reports Third Quarter 2008 Financial Results 7Orchid Cellmark Reports Third Quarter 2008 Financial Results 8Stanley to Continue Biometrics In-Service Engineering Support for U.S. Army 2Stanley to Continue Biometrics In-Service Engineering Support for U.S. Army 3
GLP expression profiling service on the Affymetrix platform. Starting material can be blood, tissue or RNA. 5 day turnaround. Standard and custom post analyses of microarray data available....
... fluorescent microscopy-based imaging system that accurately counts ... calculates cell viability, in a single test. ... variability associated with the subjective interpretation of ... EasyCount ViaSure Kit, up to six tests ...
In Western blotting antibodies recognize 94 K protein band, which corresponds to S-layer protein...
... griseolusthat inhibits protein synthesis. Acts by ... ribosomes. Reported to induce apoptosis in ... leukemia cells, Jurkat cells, ventricular myocytes, ... signals and immediate early gene induction. ...
Biology Products: